Forzinity Injection
Product Images NDC 72507-800

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 23 technical images submitted to the FDA as part of the official labeling for Forzinity (NDC 72507-800). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Stealth Biotherapeutics Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Chemical Structure (Forzinity 01)

Chemical Structure (Forzinity 01)
Chemical structure diagram of Elamipretide Hydrochloride, the active ingredient in FORZINITY injection by Stealth Biotherapeutics Inc.*
FDA Label Image

Figure 1-a (Forzinity 02)

Figure 1-a (Forzinity 02)
Illustration showing a medication vial labeled FORZINITY, a syringe, alcohol swabs, cotton balls, and a sharps disposal container, representing materials used for subcutaneous injection administration of FORZINITY (Elamipretide Hydrochloride).*
FDA Label Image

Figure 1-b (Forzinity 03)

Figure 1-b (Forzinity 03)
FORZINITY 280 mg/3.5 mL injection vial for subcutaneous administration. Label indicates the generic name Elamipretide Hydrochloride. Labeled by Stealth Biotherapeutics Inc. The vial is clear with a white label and a gray cap.*
FDA Label Image

Figure 1-c (Forzinity 04)

Figure 1-c (Forzinity 04)
An instructional illustration showing a syringe for injection, labeled with parts including plunger, barrel, needle, and cap. The diagram visually identifies each component of the syringe typically used for subcutaneous injection.*
FDA Label Image

Figure 2 (Forzinity 05)

Figure 2 (Forzinity 05)
An illustration of a vial labeled with the sections for 'LOT NO.' and 'EXP DATE.' The vial is used for injection and is shown with a cap and a label indicating where the lot number and expiration date are printed.*
FDA Label Image

Figure 3-a (Forzinity 06)

Figure 3-a (Forzinity 06)
An instructional black and white line drawing showing hands being washed under running water from a faucet over a sink. The image illustrates proper handwashing technique, likely related to injection preparation or hygiene.*
FDA Label Image

Figure 3-b (Forzinity 07)

Figure 3-b (Forzinity 07)
An instructional line drawing showing a hand removing the cap from a small vial labeled FORZINITY, a subcutaneous injection of Elamipretide Hydrochloride. An upward arrow indicates the direction to pull the vial cap off prior to use.*
FDA Label Image

Figure 3-c (Forzinity 08)

Figure 3-c (Forzinity 08)
An instructional illustration showing a person holding a vial labeled FORZINITY with one hand while removing the vial's cap with the other hand. The image demonstrates the proper technique for opening the vial for drug preparation or administration.*
FDA Label Image

Figure 4 (Forzinity 09)

Figure 4 (Forzinity 09)
An anatomical illustration showing recommended subcutaneous injection sites for FORZINITY (Elamipretide Hydrochloride). The labeled areas include the abdomen and the thigh, highlighted as grey shaded regions on a human figure.*
FDA Label Image

Figure 5-a (Forzinity 10)

Figure 5-a (Forzinity 10)
An instructional illustration showing a hand with fingers spread and an arrow pointing upward above the middle finger. A syringe is positioned below the hand, indicating preparation for a subcutaneous injection. This diagram suggests proper injection technique or site.*
FDA Label Image

Figure 5-b (Forzinity 11)

Figure 5-b (Forzinity 11)
An instructional line drawing showing a hand holding a needle or lancet above a rectangular container with an open slit on top, depicting proper disposal or insertion technique, likely related to subcutaneous injection. No text is visible.*
FDA Label Image

Figure 5-c (Forzinity 12)

Figure 5-c (Forzinity 12)
An instructional illustration showing a hand holding a syringe with a needle, preparing for an injection. The opposite hand is pressing down on the plunger, indicated by a downward arrow, demonstrating the correct technique to administer the subcutaneous injection.*
FDA Label Image

Figure 5-d (Forzinity 13)

Figure 5-d (Forzinity 13)
An instructional line drawing showing a hand holding a syringe with the needle inserted into a vial. The image emphasizes the downward direction of the syringe plunger, indicating the injection of or withdrawal from the vial.*
FDA Label Image

Figure 5-e (Forzinity 14)

Figure 5-e (Forzinity 14)
An instructional illustration showing a pair of hands preparing a subcutaneous injection. One hand holds a vial labeled "VIAL" on a flat surface, while the other hand inserts a syringe needle into the vial, with a downward arrow indicating the needle insertion action.*
FDA Label Image

Figure 6-a (Forzinity 15)

Figure 6-a (Forzinity 15)
A black and white line drawing showing a hand holding a syringe drawing liquid from a vial labeled as an injection preparation. The illustration demonstrates the process of withdrawing medication from the vial using the syringe.*
FDA Label Image

Figure 6-b (Forzinity 16)

Figure 6-b (Forzinity 16)
An instructional illustration showing a hand holding a vial labeled FORZINITY injection and drawing medication into a syringe. The image includes an arrow indicating the downward movement of the plunger during the withdrawal of the injection from the vial.*
FDA Label Image

Figure 6-c (Forzinity 17)

Figure 6-c (Forzinity 17)
An instructional illustration showing a hand holding a syringe with a vial attached to the top. The text advises tapping the barrel and pushing the plunger up to remove air bubbles from the syringe before use.*
FDA Label Image

Figure 6-d (Forzinity 18)

Figure 6-d (Forzinity 18)
An instructional diagram showing a hand holding a syringe with the needle pointing upward, indicating removal of air, and another hand holding a vial of medication on a flat surface, demonstrating the preparation step for drawing medication from the vial before injection.*
FDA Label Image

Figure 7-a (Forzinity 19)

Figure 7-a (Forzinity 19)
An instructional illustration showing a hand pinching the skin, likely demonstrating a technique related to subcutaneous injection administration.*
FDA Label Image

Figure 7-b (Forzinity 20)

Figure 7-b (Forzinity 20)
An instructional diagram showing a hand holding a syringe positioned at a 90-degree angle to the skin, demonstrating the proper technique for a subcutaneous injection.*
FDA Label Image

Figure 7-c (Forzinity 21)

Figure 7-c (Forzinity 21)
An instructional illustration showing a hand holding a syringe injecting a substance subcutaneously into the skin. The image depicts the injection technique with an arrow indicating downward motion of the syringe into the tissue.*
FDA Label Image

Figure 8 (Forzinity 22)

Figure 8 (Forzinity 22)
An instructional black-and-white line drawing showing a hand inserting a syringe into a narrow rectangular container with two vertical slots. The illustration likely demonstrates proper disposal or handling of the syringe, related to the subcutaneous injection form of the drug Forzinity (Elamipretide Hydrochloride).*
FDA Label Image

Principal Display Panel (3.5 mL Vial Carton)

Principal Display Panel (3.5 mL Vial Carton)
Packaging label for FORZINITY (elamipretide) injection, 280 mg/3.5 mL (80 mg/mL) subcutaneous injection. The label indicates it contains preservatives and is not for use in neonates. The package holds 4 single-patient-use vials and is labeled Rx only. The labeler is Stealth Biotherapeutics Inc. and the NDC is 72507-800-04.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.